Validation of a guidelines-based digital tool to assess the need for germline cancer genetic testing
Open Access
- 8 November 2024
- journal article
- research article
- Published by Springer Nature in Hereditary Cancer in Clinical Practice
- Vol. 22 (1) , 1-9
Abstract
Background: Efficient and scalable solutions are needed to identify patients who qualify for germline cancer genetic testing. We evaluated the clinical validity of a brief, patient-administered hereditary cancer risk assessment digital tool programmed to assess if patients meet criteria for germline genetic testing, based on personal and family history, and in line with national guidelines. Methods: We applied the tool to cases seen in a nationwide telehealth genetic counseling practice. Validity of the tool was evaluated by comparing the tool’s assessment to that of the genetic counselor who saw the patient. Patients’ histories were extracted from genetic counselor-collected pedigrees and input into the tool by the research team to model how a patient would complete the tool. We also validated the tool’s assessment of which specific aspects of the personal and family history met criteria for genetic testing. Descriptive statistics were used. Results: Of the 152 cases (80% female, mean age 52.3), 56% had a personal history of cancer and 66% met genetic testing criteria. The tool and genetic counselor agreed in 96% of cases. Most disagreements (4/6; 67%) occurred because the genetic counselor’s assessment relied on details the tool was not programmed to collect since patients typically don’t have access to the relevant information (pathology details, risk models). We also found complete agreement between the tool and research team on which specific aspects of the patient’s history met criteria for genetic testing. Conclusion: We observed a high level of agreement with genetic counselor assessments, affirming the tool’s clinical validity in identifying individuals for hereditary cancer predisposition testing and its potential for increasing access to hereditary cancer risk assessment.Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health systemBreast Cancer Research and Treatment, 2022
- Use of a chatbot to increase uptake of cascade genetic testingJournal of Genetic Counseling, 2022
- Increasing referral of at‐risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging centerCancer, 2021
- Population screening to identify women at risk for hereditary breast cancer syndromes: The path forward or the road not taken?Cancer, 2021
- Chatbots & artificial intelligence to scale genetic information deliveryJournal of Genetic Counseling, 2020
- Risk Assessment, Genetic Counseling, and Genetic Testing forBRCA-Related CancerJAMA, 2019
- Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutationsSupportive Care in Cancer, 2018
- BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelinesFamilial Cancer, 2016
- Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessmentFamilial Cancer, 2015
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010